{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:14:30Z","timestamp":1791346470641,"version":"4.3.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL159983"],"award-info":[{"award-number":["R01HL159983"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL170196"],"award-info":[{"award-number":["R01HL170196"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL159983"],"award-info":[{"award-number":["R01HL159983"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL170196"],"award-info":[{"award-number":["R01HL170196"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R21AG074593"],"award-info":[{"award-number":["R21AG074593"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R21AG074593"],"award-info":[{"award-number":["R21AG074593"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Regen Med"],"DOI":"10.1038\/s41536-024-00380-0","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T10:57:43Z","timestamp":1733828263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cardiac bridging integrator 1 gene therapy rescues chronic non-ischemic heart failure in minipigs"],"prefix":"10.1038","volume":"9","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Balmaceda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8490-6111","authenticated-orcid":false,"given":"Joseph R.","family":"Visker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Maalouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume L.","family":"Hoareau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Accad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig H.","family":"Selzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros G.","family":"Drakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0243-5046","authenticated-orcid":false,"given":"TingTing","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"380_CR1","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese, G. et al. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc. Res. 118, 3272\u20133287 (2023).","journal-title":"Cardiovasc. Res."},{"key":"380_CR2","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich, P. A. et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 79, 1757\u20131780 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"380_CR3","doi-asserted-by":"publisher","first-page":"e012239","DOI":"10.1161\/JAHA.119.012239","volume":"8","author":"JM Kieserman","year":"2019","unstructured":"Kieserman, J. M., Myers, V. D., Dubey, P., Cheung, J. Y. & Feldman, A. M. Current landscape of heart failure gene therapy. J. Am. Heart Assoc. 8, e012239 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"380_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41569-020-00499-9","volume":"18","author":"S Sahoo","year":"2021","unstructured":"Sahoo, S., Kariya, T. & Ishikawa, K. Targeted delivery of therapeutic agents to the heart. Nat. Rev. Cardiol. 18, 389\u2013399 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"380_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jchf.2023.09.015","volume":"12","author":"A Argiro","year":"2024","unstructured":"Argiro, A. et al. Applications of gene therapy in cardiomyopathies. JACC Heart Fail 12, 248\u2013260 (2024).","journal-title":"JACC Heart Fail"},{"key":"380_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2023.101636","volume":"70","author":"N Vora","year":"2024","unstructured":"Vora, N. et al. Gene therapy for heart failure: a novel treatment for the age old disease. Dis. Mon. 70, 101636 (2024).","journal-title":"Dis. Mon."},{"key":"380_CR7","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nm.3543","volume":"20","author":"T Hong","year":"2014","unstructured":"Hong, T. et al. Cardiac BIN1 folds T-tubule membrane, controlling ion flux and limiting arrhythmia. Nat. Med. 20, 624\u2013632 (2014).","journal-title":"Nat. Med."},{"key":"380_CR8","doi-asserted-by":"publisher","first-page":"e1000312","DOI":"10.1371\/journal.pbio.1000312","volume":"8","author":"TT Hong","year":"2010","unstructured":"Hong, T. T. et al. BIN1 localizes the L-type calcium channel to cardiac T-tubules. PLoS Biol. 8, e1000312 (2010).","journal-title":"PLoS Biol."},{"key":"380_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.115.018535","volume":"133","author":"Y Fu","year":"2016","unstructured":"Fu, Y. et al. Isoproterenol promotes rapid ryanodine receptor movement to bridging integrator 1 (BIN1)-organized dyads. Circulation 133, 388\u2013397 (2016).","journal-title":"Circulation"},{"key":"380_CR10","doi-asserted-by":"publisher","first-page":"e166713","DOI":"10.1172\/jci.insight.166713","volume":"8","author":"J Li","year":"2023","unstructured":"Li, J. et al. Cardiac gene therapy treats diabetic cardiomyopathy and lowers blood glucose. JCI Insight 8, e166713 (2023).","journal-title":"JCI Insight"},{"key":"380_CR11","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamacardio.2018.3539","volume":"3","author":"AP Nikolova","year":"2018","unstructured":"Nikolova, A. P. et al. Association of a novel diagnostic biomarker, the plasma cardiac bridging integrator 1 score, with heart failure with preserved ejection fraction and cardiovascular hospitalization. JAMA Cardiol. 3, 1206\u20131210 (2018).","journal-title":"JAMA Cardiol."},{"key":"380_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3389\/fphys.2020.00503","volume":"11","author":"TC Hitzeman","year":"2020","unstructured":"Hitzeman, T. C. et al. cBIN1 score (CS) identifies ambulatory HFrEF patients and predicts cardiovascular events. Front. Physiol. 11, 503 (2020).","journal-title":"Front. Physiol."},{"key":"380_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jacbts.2020.03.006","volume":"5","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. In mice subjected to chronic stress, exogenous cBIN1 preserves calcium-handling machinery and cardiac function. JACC Basic Transl. Sci. 5, 561\u2013578 (2020).","journal-title":"JACC Basic Transl. Sci."},{"key":"380_CR14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3389\/fphys.2020.00708","volume":"11","author":"J Li","year":"2020","unstructured":"Li, J., Agvanian, S., Zhou, K., Shaw, R. M. & Hong, T. Exogenous Cardiac bridging integrator 1 benefits mouse hearts with pre-existing pressure overload-induced heart failure. Front. Physiol. 11, 708 (2020).","journal-title":"Front. Physiol."},{"key":"380_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jacbts.2020.04.011","volume":"5","author":"KAS Silva","year":"2020","unstructured":"Silva, K. A. S. & Emter, C. A. Large animal models of heart failure: a translational bridge to clinical success. JACC Basic Transl. Sci. 5, 840\u2013856 (2020).","journal-title":"JACC Basic Transl. Sci."},{"key":"380_CR16","first-page":"H218","volume":"259","author":"FG Spinale","year":"1990","unstructured":"Spinale, F. G. et al. Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine. Am. J. Physiol. 259, H218\u2013H229 (1990).","journal-title":"Am. J. Physiol."},{"key":"380_CR17","first-page":"H594","volume":"270","author":"MT Rademaker","year":"1996","unstructured":"Rademaker, M. T. et al. Natriuretic peptide responses to acute and chronic ventricular pacing in sheep. Am. J. Physiol. 270, H594\u2013H602 (1996).","journal-title":"Am. J. Physiol."},{"key":"380_CR18","first-page":"H1603","volume":"258","author":"E Chow","year":"1990","unstructured":"Chow, E., Woodard, J. C. & Farrar, D. J. Rapid ventricular pacing in pigs: an experimental model of congestive heart failure. Am. J. Physiol. 258, H1603\u2013H1605 (1990).","journal-title":"Am. J. Physiol."},{"key":"380_CR19","doi-asserted-by":"crossref","unstructured":"Hala, P. et al. Tachycardia-induced cardiomyopathy as a chronic heart failure model in swine. J. Vis. Exp. (132), 57030 (2018).","DOI":"10.3791\/57030"},{"key":"380_CR20","doi-asserted-by":"crossref","unstructured":"Masarone, D. et al. Management of arrhythmias in heart failure. J. Cardiovasc. Dev. Dis. 4, 3 (2017).","DOI":"10.3390\/jcdd4010003"},{"key":"380_CR21","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.hrthm.2011.11.055","volume":"9","author":"TT Hong","year":"2012","unstructured":"Hong, T. T. et al. BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes. Heart Rhythm 9, 812\u2013820 (2012).","journal-title":"Heart Rhythm"},{"key":"380_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","volume":"124","author":"M Jessup","year":"2011","unstructured":"Jessup, M. et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 124, 304\u2013313 (2011).","journal-title":"Circulation"},{"key":"380_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jchf.2013.09.008","volume":"2","author":"B Greenberg","year":"2014","unstructured":"Greenberg, B. et al. Design of a phase 2b trial of intracoronary administration of AAV1\/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b). JACC Heart Fail. 2, 84\u201392 (2014).","journal-title":"JACC Heart Fail."},{"key":"380_CR24","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1056\/NEJMoa2104205","volume":"385","author":"LA George","year":"2021","unstructured":"George, L. A. et al. Multiyear factor VIII expression after AAV gene transfer for hemophilia A. N. Engl. J. Med. 385, 1961\u20131973 (2021).","journal-title":"N. Engl. J. Med."},{"key":"380_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1056\/NEJMoa2119913","volume":"387","author":"P Chowdary","year":"2022","unstructured":"Chowdary, P. et al. Phase 1-2 trial of AAVS3 gene therapy in patients with hemophilia B. N. Engl. J. Med. 387, 237\u2013247 (2022).","journal-title":"N. Engl. J. Med."},{"key":"380_CR26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1056\/NEJMoa2211075","volume":"388","author":"J Mahlangu","year":"2023","unstructured":"Mahlangu, J. et al. Two-year outcomes of valoctocogene roxaparvovec therapy for hemophilia A. N. Engl. J. Med. 388, 694\u2013705 (2023).","journal-title":"N. Engl. J. Med."},{"key":"380_CR27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1056\/NEJMoa2211644","volume":"388","author":"SW Pipe","year":"2023","unstructured":"Pipe, S. W. et al. Gene therapy with etranacogene dezaparvovec for hemophilia B. N. Engl. J. Med. 388, 706\u2013718 (2023).","journal-title":"N. Engl. J. Med."},{"key":"380_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/gt.2010.105","volume":"18","author":"KM Prasad","year":"2011","unstructured":"Prasad, K. M., Xu, Y., Yang, Z., Acton, S. T. & French, B. A. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther. 18, 43\u201352 (2011).","journal-title":"Gene Ther."},{"key":"380_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1089\/hum.2006.17.427","volume":"17","author":"R Sarkar","year":"2006","unstructured":"Sarkar, R. et al. Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia a dogs and mice. Hum. Gene Ther. 17, 427\u2013439 (2006).","journal-title":"Hum. Gene Ther."},{"key":"380_CR30","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.1128\/JVI.07232-11","volume":"86","author":"MA DiMattia","year":"2012","unstructured":"DiMattia, M. A. et al. Structural insight into the unique properties of adeno-associated virus serotype 9. J. Virol. 86, 6947\u20136958 (2012).","journal-title":"J. Virol."},{"key":"380_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3389\/fimmu.2013.00341","volume":"4","author":"R Calcedo","year":"2013","unstructured":"Calcedo, R. & Wilson, J. M. Humoral immune response to AAV. Front Immunol. 4, 341 (2013).","journal-title":"Front Immunol."},{"key":"380_CR32","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1053\/euhj.1997.0852","volume":"19","author":"M St John Sutton","year":"1998","unstructured":"St John Sutton, M. et al. Quantitation of left ventricular volumes and ejection fraction in post-infarction patients from biplane and single plane two-dimensional echocardiograms. A prospective longitudinal study of 371 patients. Eur. Heart J. 19, 808\u2013816 (1998).","journal-title":"Eur. Heart J."},{"key":"380_CR33","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1161\/CIRCRESAHA.109.212324","volume":"107","author":"S Wei","year":"2010","unstructured":"Wei, S. et al. T-tubule remodeling during transition from hypertrophy to heart failure. Circ. Res. 107, 520\u2013531 (2010).","journal-title":"Circ. Res."},{"key":"380_CR34","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1016\/j.bpj.2014.05.013","volume":"106","author":"A Guo","year":"2014","unstructured":"Guo, A. & Song, L. S. AutoTT: automated detection and analysis of T-tubule architecture in cardiomyocytes. Biophys. J. 106, 2729\u20132736 (2014).","journal-title":"Biophys. J."}],"container-title":["npj Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41536-024-00380-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-024-00380-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-024-00380-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T11:06:44Z","timestamp":1733828804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41536-024-00380-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1038\/s41536-024-00380-0","relation":{},"ISSN":["2057-3995"],"issn-type":[{"value":"2057-3995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Utah has submitted a provisional patent application: \u201cMethods for rehabilitating heart failure using gene therapy\u201d (US 63\/088, 123, TT.H. and R.M.S), which has been licensed by TikkunLev Inc. TT.H and R.M.S received a Sponsored Research Award and stock options from TikkunLev Inc. Disclosures for S.G.D.: Consultant: Abbott, Research Support: Novartis. No other conflict of interest exists. Other authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}